APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ophthalmic Drug Delivery System

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Ophthalmic Drug Delivery System Industry Growth and Trends Forecast to 2032

4 July 2026125 pages

Choose your research edition.

Industry ResearchOphthalmic Drug Delivery System Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Ophthalmic Drug Delivery System Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Ophthalmic Drug Delivery System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ophthalmic Drug Delivery System Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Ophthalmic Drug Delivery System Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Ophthalmic Drug Delivery System market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Ophthalmic Drug Delivery System is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Ophthalmic Drug Delivery System is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ophthalmic Drug Delivery System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ophthalmic Drug Delivery System include Aero Pump GmbH, AptarGroup, Bausch Health, Becton Dickinson & Company, Biocorp Production, Clearside Biomedical, Envisia Therapeutics, EyePoint Pharmaceuticals, Inc. and Gaplast GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Ophthalmic Drug Delivery System market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Ophthalmic Drug Delivery System market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ophthalmic Drug Delivery System market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ophthalmic Drug Delivery System.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Ophthalmic Drug Delivery System market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Ophthalmic Drug Delivery System Market by Company

Aero Pump GmbH

AptarGroup

Bausch Health

Becton Dickinson & Company

Biocorp Production

Clearside Biomedical

Envisia Therapeutics

EyePoint Pharmaceuticals, Inc.

Gaplast GmbH

Gerresheimer

Graybug Vision

Kedalion Therapeutics

Mati Therapeutics, Inc.,

Nemera

Nipro Corporation

Ocular Therapeutix

Ocumedic, Inc.

Owen Mumford

Re-Vana Therapeutics

Santen Pharmaceutical

Silgan Holdings Inc.

Taiwan Liposome

Terumo Corporation

West Pharmaceutical Services, Inc.

Ophthalmic Drug Delivery System Segment by Type

Implantable Ophthalmic Drug Delivery Systems

Particulate Ophthalmic Drug Delivery Systems

Others

Ophthalmic Drug Delivery System Segment by Application

Clinics

Hospitals

Ambulatory Surgical Centers

Others

Ophthalmic Drug Delivery System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ophthalmic Drug Delivery System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ophthalmic Drug Delivery System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ophthalmic Drug Delivery System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ophthalmic Drug Delivery System manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Ophthalmic Drug Delivery System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Implantable Ophthalmic Drug Delivery Systems Table 2. Major Company of Particulate Ophthalmic Drug Delivery Systems Table 3. Major Company of Others Table 4. Global Ophthalmic Drug Delivery System Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Ophthalmic Drug Delivery System Sales by Type (2021-2026) & (k units) Table 6. Global Ophthalmic Drug Delivery System Sales Market Share in Volume by Type (2021-2026) Table 7. Global Ophthalmic Drug Delivery System Sales by Type (2021-2026) & (US$ Million) Table 8. Global Ophthalmic Drug Delivery System Sales Market Share in Value by Type (2021-2026) Table 9. Global Ophthalmic Drug Delivery System Price by Type (2021-2026) & (USD/unit) Table 10. Global Ophthalmic Drug Delivery System Sales by Type (2027-2032) & (k units) Table 11. Global Ophthalmic Drug Delivery System Sales Market Share in Volume by Type (2027-2032) Table 12. Global Ophthalmic Drug Delivery System Sales by Type (2027-2032) & (US$ Million) Table 13. Global Ophthalmic Drug Delivery System Sales Market Share in Value by Type (2027-2032) Table 14. Global Ophthalmic Drug Delivery System Price by Type (2027-2032) & (USD/unit) Table 15. North America Ophthalmic Drug Delivery System Sales by Type (2021-2026) & (k units) Table 16. North America Ophthalmic Drug Delivery System Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Ophthalmic Drug Delivery System Sales by Type (2021-2026) & (k units) Table 18. Europe Ophthalmic Drug Delivery System Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Ophthalmic Drug Delivery System Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Ophthalmic Drug Delivery System Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Ophthalmic Drug Delivery System Sales by Type (2021-2026) & (k units) Table 22. Latin America Ophthalmic Drug Delivery System Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Ophthalmic Drug Delivery System Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Ophthalmic Drug Delivery System Sales by Type (2021-2026) & (US$ Million) Table 25. Ophthalmic Drug Delivery System Industry Trends Table 26. Ophthalmic Drug Delivery System Industry Drivers Table 27. Ophthalmic Drug Delivery System Industry Opportunities and Challenges Table 28. Ophthalmic Drug Delivery System Industry Restraints Table 29. Global Ophthalmic Drug Delivery System Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Ophthalmic Drug Delivery System Revenue Market Share by Company (2021-2026) Table 31. Global Ophthalmic Drug Delivery System Sales by Company (2021-2026) & (k units) Table 32. Global Ophthalmic Drug Delivery System Sales Share by Company (2021-2026) Table 33. Global Ophthalmic Drug Delivery System Market Price by Company (2021-2026) & (USD/unit) Table 34. Global Ophthalmic Drug Delivery System Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Ophthalmic Drug Delivery System Major Company Production Sites and Headquarters Table 36. Global Ophthalmic Drug Delivery System Company, Product Type & Application Table 37. Global Ophthalmic Drug Delivery System Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Ophthalmic Drug Delivery System by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Ophthalmic Drug Delivery System Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Ophthalmic Drug Delivery System Sales by Region (2021-2026) & (k units) Table 42. Global Ophthalmic Drug Delivery System Sales Market Share in Volume by Region (2021-2026) Table 43. Global Ophthalmic Drug Delivery System Sales by Region (2021-2026) & (US$ Million) Table 44. Global Ophthalmic Drug Delivery System Sales Market Share in Value by Region (2021-2026) Table 45. Global Ophthalmic Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Global Ophthalmic Drug Delivery System Sales by Region (2027-2032) & (k units) Table 47. Global Ophthalmic Drug Delivery System Sales Market Share in Volume by Region (2027-2032) Table 48. Global Ophthalmic Drug Delivery System Sales by Region (2027-2032) & (US$ Million) Table 49. Global Ophthalmic Drug Delivery System Sales Market Share in Value by Region (2027-2032) Table 50. Global Ophthalmic Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 51. Global Ophthalmic Drug Delivery System Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Ophthalmic Drug Delivery System Sales by Application (2021-2026) & (k units) Table 53. Global Ophthalmic Drug Delivery System Sales Market Share in Volume by Application (2021-2026) Table 54. Global Ophthalmic Drug Delivery System Sales by Application (2021-2026) & (US$ Million) Table 55. Global Ophthalmic Drug Delivery System Sales Market Share in Value by Application (2021-2026) Table 56. Global Ophthalmic Drug Delivery System Price by Application (2021-2026) & (USD/unit) Table 57. Global Ophthalmic Drug Delivery System Sales by Application (2027-2032) & (k units) Table 58. Global Ophthalmic Drug Delivery System Sales Market Share in Volume by Application (2027-2032) Table 59. Global Ophthalmic Drug Delivery System Sales by Application (2027-2032) & (US$ Million) Table 60. Global Ophthalmic Drug Delivery System Sales Market Share in Value by Application (2027-2032) Table 61. Global Ophthalmic Drug Delivery System Price by Application (2027-2032) & (USD/unit) Table 62. North America Ophthalmic Drug Delivery System Sales by Application (2021-2026) & (k units) Table 63. North America Ophthalmic Drug Delivery System Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Ophthalmic Drug Delivery System Sales by Application (2021-2026) & (k units) Table 65. Europe Ophthalmic Drug Delivery System Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Ophthalmic Drug Delivery System Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Ophthalmic Drug Delivery System Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Ophthalmic Drug Delivery System Sales by Application (2021-2026) & (k units) Table 69. Latin America Ophthalmic Drug Delivery System Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Ophthalmic Drug Delivery System Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Ophthalmic Drug Delivery System Sales by Application (2021-2026) & (US$ Million) Table 72. Aero Pump GmbH Company Information Table 73. Aero Pump GmbH Business Overview Table 74. Aero Pump GmbH Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. Aero Pump GmbH Ophthalmic Drug Delivery System Product Portfolio Table 76. Aero Pump GmbH Recent Development Table 77. AptarGroup Company Information Table 78. AptarGroup Business Overview Table 79. AptarGroup Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. AptarGroup Ophthalmic Drug Delivery System Product Portfolio Table 81. AptarGroup Recent Development Table 82. Bausch Health Company Information Table 83. Bausch Health Business Overview Table 84. Bausch Health Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. Bausch Health Ophthalmic Drug Delivery System Product Portfolio Table 86. Bausch Health Recent Development Table 87. Becton Dickinson & Company Company Information Table 88. Becton Dickinson & Company Business Overview Table 89. Becton Dickinson & Company Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Becton Dickinson & Company Ophthalmic Drug Delivery System Product Portfolio Table 91. Becton Dickinson & Company Recent Development Table 92. Biocorp Production Company Information Table 93. Biocorp Production Business Overview Table 94. Biocorp Production Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Biocorp Production Ophthalmic Drug Delivery System Product Portfolio Table 96. Biocorp Production Recent Development Table 97. Clearside Biomedical Company Information Table 98. Clearside Biomedical Business Overview Table 99. Clearside Biomedical Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Clearside Biomedical Ophthalmic Drug Delivery System Product Portfolio Table 101. Clearside Biomedical Recent Development Table 102. Envisia Therapeutics Company Information Table 103. Envisia Therapeutics Business Overview Table 104. Envisia Therapeutics Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Envisia Therapeutics Ophthalmic Drug Delivery System Product Portfolio Table 106. Envisia Therapeutics Recent Development Table 107. EyePoint Pharmaceuticals, Inc. Company Information Table 108. EyePoint Pharmaceuticals, Inc. Business Overview Table 109. EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Product Portfolio Table 111. EyePoint Pharmaceuticals, Inc. Recent Development Table 112. Gaplast GmbH Company Information Table 113. Gaplast GmbH Business Overview Table 114. Gaplast GmbH Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Gaplast GmbH Ophthalmic Drug Delivery System Product Portfolio Table 116. Gaplast GmbH Recent Development Table 117. Gerresheimer Company Information Table 118. Gerresheimer Business Overview Table 119. Gerresheimer Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Gerresheimer Ophthalmic Drug Delivery System Product Portfolio Table 121. Gerresheimer Recent Development Table 122. Graybug Vision Company Information Table 123. Graybug Vision Business Overview Table 124. Graybug Vision Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Graybug Vision Ophthalmic Drug Delivery System Product Portfolio Table 126. Graybug Vision Recent Development Table 127. Kedalion Therapeutics Company Information Table 128. Kedalion Therapeutics Business Overview Table 129. Kedalion Therapeutics Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Kedalion Therapeutics Ophthalmic Drug Delivery System Product Portfolio Table 131. Kedalion Therapeutics Recent Development Table 132. Mati Therapeutics, Inc., Company Information Table 133. Mati Therapeutics, Inc., Business Overview Table 134. Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Product Portfolio Table 136. Mati Therapeutics, Inc., Recent Development Table 137. Nemera Company Information Table 138. Nemera Business Overview Table 139. Nemera Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. Nemera Ophthalmic Drug Delivery System Product Portfolio Table 141. Nemera Recent Development Table 142. Nipro Corporation Company Information Table 143. Nipro Corporation Business Overview Table 144. Nipro Corporation Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. Nipro Corporation Ophthalmic Drug Delivery System Product Portfolio Table 146. Nipro Corporation Recent Development Table 147. Ocular Therapeutix Company Information Table 148. Ocular Therapeutix Business Overview Table 149. Ocular Therapeutix Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. Ocular Therapeutix Ophthalmic Drug Delivery System Product Portfolio Table 151. Ocular Therapeutix Recent Development Table 152. Ocumedic, Inc. Company Information Table 153. Ocumedic, Inc. Business Overview Table 154. Ocumedic, Inc. Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 155. Ocumedic, Inc. Ophthalmic Drug Delivery System Product Portfolio Table 156. Ocumedic, Inc. Recent Development Table 157. Owen Mumford Company Information Table 158. Owen Mumford Business Overview Table 159. Owen Mumford Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 160. Owen Mumford Ophthalmic Drug Delivery System Product Portfolio Table 161. Owen Mumford Recent Development Table 162. Re-Vana Therapeutics Company Information Table 163. Re-Vana Therapeutics Business Overview Table 164. Re-Vana Therapeutics Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 165. Re-Vana Therapeutics Ophthalmic Drug Delivery System Product Portfolio Table 166. Re-Vana Therapeutics Recent Development Table 167. Santen Pharmaceutical Company Information Table 168. Santen Pharmaceutical Business Overview Table 169. Santen Pharmaceutical Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 170. Santen Pharmaceutical Ophthalmic Drug Delivery System Product Portfolio Table 171. Santen Pharmaceutical Recent Development Table 172. Silgan Holdings Inc. Company Information Table 173. Silgan Holdings Inc. Business Overview Table 174. Silgan Holdings Inc. Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 175. Silgan Holdings Inc. Ophthalmic Drug Delivery System Product Portfolio Table 176. Silgan Holdings Inc. Recent Development Table 177. Taiwan Liposome Company Information Table 178. Taiwan Liposome Business Overview Table 179. Taiwan Liposome Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 180. Taiwan Liposome Ophthalmic Drug Delivery System Product Portfolio Table 181. Taiwan Liposome Recent Development Table 182. Terumo Corporation Company Information Table 183. Terumo Corporation Business Overview Table 184. Terumo Corporation Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 185. Terumo Corporation Ophthalmic Drug Delivery System Product Portfolio Table 186. Terumo Corporation Recent Development Table 187. West Pharmaceutical Services, Inc. Company Information Table 188. West Pharmaceutical Services, Inc. Business Overview Table 189. West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 190. West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Product Portfolio Table 191. West Pharmaceutical Services, Inc. Recent Development Table 192. North America Ophthalmic Drug Delivery System Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 193. North America Ophthalmic Drug Delivery System Sales by Country (2021-2026) & (k units) Table 194. North America Ophthalmic Drug Delivery System Sales Market Share by Country (2021-2026) Table 195. North America Ophthalmic Drug Delivery System Sales Forecast by Country (2027-2032) & (k units) Table 196. North America Ophthalmic Drug Delivery System Sales Market Share Forecast by Country (2027-2032) Table 197. North America Ophthalmic Drug Delivery System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 198. North America Ophthalmic Drug Delivery System Market Size by Country (2021-2026) & (US$ Million) Table 199. North America Ophthalmic Drug Delivery System Market Share by Country (2021-2026) Table 200. North America Ophthalmic Drug Delivery System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 201. North America Ophthalmic Drug Delivery System Market Share Forecast by Country (2027-2032) Table 202. Europe Ophthalmic Drug Delivery System Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 203. Europe Ophthalmic Drug Delivery System Sales by Country (2021-2026) & (k units) Table 204. Europe Ophthalmic Drug Delivery System Sales Market Share by Country (2021-2026) Table 205. Europe Ophthalmic Drug Delivery System Sales Forecast by Country (2027-2032) & (k units) Table 206. Europe Ophthalmic Drug Delivery System Sales Market Share Forecast by Country (2027-2032) Table 207. Europe Ophthalmic Drug Delivery System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 208. Europe Ophthalmic Drug Delivery System Market Size by Country (2021-2026) & (US$ Million) Table 209. Europe Ophthalmic Drug Delivery System Market Share by Country (2021-2026) Table 210. Europe Ophthalmic Drug Delivery System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 211. Europe Ophthalmic Drug Delivery System Market Share Forecast by Country (2027-2032) Table 212. Asia-Pacific Ophthalmic Drug Delivery System Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 213. Asia-Pacific Ophthalmic Drug Delivery System Sales by Country (2021-2026) & (k units) Table 214. Asia-Pacific Ophthalmic Drug Delivery System Sales Market Share by Country (2021-2026) Table 215. Asia-Pacific Ophthalmic Drug Delivery System Sales Forecast by Country (2027-2032) & (k units) Table 216. Asia-Pacific Ophthalmic Drug Delivery System Sales Market Share Forecast by Country (2027-2032) Table 217. Asia-Pacific Ophthalmic Drug Delivery System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 218. Asia-Pacific Ophthalmic Drug Delivery System Market Size by Country (2021-2026) & (US$ Million) Table 219. Asia-Pacific Ophthalmic Drug Delivery System Market Share by Country (2021-2026) Table 220. Asia-Pacific Ophthalmic Drug Delivery System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 221. Asia-Pacific Ophthalmic Drug Delivery System Market Share Forecast by Country (2027-2032) Table 222. Latin America Ophthalmic Drug Delivery System Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 223. Latin America Ophthalmic Drug Delivery System Sales by Country (2021-2026) & (k units) Table 224. Latin America Ophthalmic Drug Delivery System Sales Market Share by Country (2021-2026) Table 225. Latin America Ophthalmic Drug Delivery System Sales Forecast by Country (2027-2032) & (k units) Table 226. Latin America Ophthalmic Drug Delivery System Sales Market Share Forecast by Country (2027-2032) Table 227. Latin America Ophthalmic Drug Delivery System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 228. Latin America Ophthalmic Drug Delivery System Market Size by Country (2021-2026) & (US$ Million) Table 229. Latin America Ophthalmic Drug Delivery System Market Share by Country (2021-2026) Table 230. Latin America Ophthalmic Drug Delivery System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 231. Latin America Ophthalmic Drug Delivery System Market Share Forecast by Country (2027-2032) Table 232. Middle East and Africa Ophthalmic Drug Delivery System Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 233. Middle East and Africa Ophthalmic Drug Delivery System Sales by Country (2021-2026) & (k units) Table 234. Middle East and Africa Ophthalmic Drug Delivery System Sales Market Share by Country (2021-2026) Table 235. Middle East and Africa Ophthalmic Drug Delivery System Sales Forecast by Country (2027-2032) & (k units) Table 236. Middle East and Africa Ophthalmic Drug Delivery System Sales Market Share Forecast by Country (2027-2032) Table 237. Middle East and Africa Ophthalmic Drug Delivery System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 238. Middle East and Africa Ophthalmic Drug Delivery System Market Size by Country (2021-2026) & (US$ Million) Table 239. Middle East and Africa Ophthalmic Drug Delivery System Market Share by Country (2021-2026) Table 240. Middle East and Africa Ophthalmic Drug Delivery System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 241. Middle East and Africa Ophthalmic Drug Delivery System Market Share Forecast by Country (2027-2032) Table 242. Key Raw Materials Table 243. Raw Materials Key Suppliers Table 244. Ophthalmic Drug Delivery System Distributors List Table 245. Ophthalmic Drug Delivery System Customers List Table 246. Research Programs/Design for This Report Table 247. Authors List of This Report Table 248. Secondary Sources Table 249. Primary Sources List of Figures Figure 1. Ophthalmic Drug Delivery System Image Figure 2. Global Ophthalmic Drug Delivery System Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ophthalmic Drug Delivery System Market Size (2021-2032) & (US$ Million) Figure 4. Global Ophthalmic Drug Delivery System Sales (2021-2032) & (k units) Figure 5. Implantable Ophthalmic Drug Delivery Systems Image Figure 6. Global Implantable Ophthalmic Drug Delivery Systems Sales YoY Growth (2021-2032) & (k units) Figure 7. Particulate Ophthalmic Drug Delivery Systems Image Figure 8. Global Particulate Ophthalmic Drug Delivery Systems Sales YoY Growth (2021-2032) & (k units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Ophthalmic Drug Delivery System Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Ophthalmic Drug Delivery System Market Share by Type 2025 VS 2032 Figure 13. North America Ophthalmic Drug Delivery System Sales Market Share in Volume by Type in 2025 Figure 14. North America Ophthalmic Drug Delivery System Sales Market Share in Value by Type in 2025 Figure 15. Europe Ophthalmic Drug Delivery System Sales Market Share in Volume by Type in 2025 Figure 16. Europe Ophthalmic Drug Delivery System Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Ophthalmic Drug Delivery System Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Ophthalmic Drug Delivery System Sales Market Share in Value by Type in 2025 Figure 19. Latin America Ophthalmic Drug Delivery System Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Ophthalmic Drug Delivery System Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Ophthalmic Drug Delivery System Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Ophthalmic Drug Delivery System Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Ophthalmic Drug Delivery System Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Clinics Image Figure 26. Global Clinics Sales YoY Growth (2021-2032) & (k units) Figure 27. Hospitals Image Figure 28. Global Hospitals Sales YoY Growth (2021-2032) & (k units) Figure 29. Ambulatory Surgical Centers Image Figure 30. Global Ambulatory Surgical Centers Sales YoY Growth (2021-2032) & (k units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Ophthalmic Drug Delivery System Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Ophthalmic Drug Delivery System Market Share by Application 2025 VS 2032 Figure 35. North America Ophthalmic Drug Delivery System Sales Market Share in Volume by Application in 2025 Figure 36. North America Ophthalmic Drug Delivery System Sales Market Share in Value by Application in 2025 Figure 37. Europe Ophthalmic Drug Delivery System Sales Market Share in Volume by Application in 2025 Figure 38. Europe Ophthalmic Drug Delivery System Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Ophthalmic Drug Delivery System Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Ophthalmic Drug Delivery System Sales Market Share in Value by Application in 2025 Figure 41. Latin America Ophthalmic Drug Delivery System Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Ophthalmic Drug Delivery System Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Ophthalmic Drug Delivery System Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Ophthalmic Drug Delivery System Sales Market Share in Value by Application in 2025 Figure 45. North America Ophthalmic Drug Delivery System Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Ophthalmic Drug Delivery System Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Ophthalmic Drug Delivery System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Ophthalmic Drug Delivery System Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Ophthalmic Drug Delivery System Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Ophthalmic Drug Delivery System Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Ophthalmic Drug Delivery System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Ophthalmic Drug Delivery System Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Ophthalmic Drug Delivery System Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Ophthalmic Drug Delivery System Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Ophthalmic Drug Delivery System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Ophthalmic Drug Delivery System Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Ophthalmic Drug Delivery System Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Ophthalmic Drug Delivery System Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Ophthalmic Drug Delivery System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Ophthalmic Drug Delivery System Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Ophthalmic Drug Delivery System Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Ophthalmic Drug Delivery System Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Ophthalmic Drug Delivery System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Ophthalmic Drug Delivery System Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Ophthalmic Drug Delivery System Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Ophthalmic Drug Delivery System Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Implantable Ophthalmic Drug Delivery Systems
  • Particulate Ophthalmic Drug Delivery Systems
  • Others
Applications
  • Clinics
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
Companies covered
  • Aero Pump GmbH
  • AptarGroup
  • Bausch Health
  • Becton Dickinson & Company
  • Biocorp Production
  • Clearside Biomedical
  • Envisia Therapeutics
  • EyePoint Pharmaceuticals, Inc.
  • Gaplast GmbH
  • Gerresheimer
  • Graybug Vision
  • Kedalion Therapeutics
  • Mati Therapeutics, Inc.,
  • Nemera
  • Nipro Corporation
  • Ocular Therapeutix
  • Ocumedic, Inc.
  • Owen Mumford
  • Re-Vana Therapeutics
  • Santen Pharmaceutical
  • Silgan Holdings Inc.
  • Taiwan Liposome
  • Terumo Corporation
  • West Pharmaceutical Services, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ophthalmic Drug Delivery System Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Ophthalmic Drug Delivery System Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Ophthalmic Drug Delivery System Market by Type
  6. 1.3.1 Implantable Ophthalmic Drug Delivery Systems
  7. 1.3.2 Particulate Ophthalmic Drug Delivery Systems
  8. 1.3.3 Others
  9. 1.4 Global Ophthalmic Drug Delivery System Market Size by Type
  10. 1.4.1 Global Ophthalmic Drug Delivery System Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Ophthalmic Drug Delivery System Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Ophthalmic Drug Delivery System Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Ophthalmic Drug Delivery System Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Ophthalmic Drug Delivery System Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Ophthalmic Drug Delivery System Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Ophthalmic Drug Delivery System Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Ophthalmic Drug Delivery System Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Ophthalmic Drug Delivery System Industry Trends
  2. 2.2 Ophthalmic Drug Delivery System Industry Drivers
  3. 2.3 Ophthalmic Drug Delivery System Industry Opportunities and Challenges
  4. 2.4 Ophthalmic Drug Delivery System Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Ophthalmic Drug Delivery System Revenue (2021-2026)
  2. 3.2 Global Top Players by Ophthalmic Drug Delivery System Sales (2021-2026)
  3. 3.3 Global Top Players by Ophthalmic Drug Delivery System Price (2021-2026)
  4. 3.4 Global Ophthalmic Drug Delivery System Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ophthalmic Drug Delivery System Major Company Production Sites & Headquarters
  6. 3.6 Global Ophthalmic Drug Delivery System Company, Product Type & Application
  7. 3.7 Global Ophthalmic Drug Delivery System Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ophthalmic Drug Delivery System Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ophthalmic Drug Delivery System Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ophthalmic Drug Delivery System Tier 1, Tier 2, and Tier 3
4 Ophthalmic Drug Delivery System Regional Status and Outlook
  1. 4.1 Global Ophthalmic Drug Delivery System Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Ophthalmic Drug Delivery System Historic Market Size by Region
  3. 4.2.1 Global Ophthalmic Drug Delivery System Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Ophthalmic Drug Delivery System Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Ophthalmic Drug Delivery System Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Ophthalmic Drug Delivery System Forecasted Market Size by Region
  7. 4.3.1 Global Ophthalmic Drug Delivery System Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Ophthalmic Drug Delivery System Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Ophthalmic Drug Delivery System Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Ophthalmic Drug Delivery System by Application
  1. 5.1 Ophthalmic Drug Delivery System Market by Application
  2. 5.1.1 Clinics
  3. 5.1.2 Hospitals
  4. 5.1.3 Ambulatory Surgical Centers
  5. 5.1.4 Others
  6. 5.2 Global Ophthalmic Drug Delivery System Market Size by Application
  7. 5.2.1 Global Ophthalmic Drug Delivery System Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Ophthalmic Drug Delivery System Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Ophthalmic Drug Delivery System Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Ophthalmic Drug Delivery System Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Ophthalmic Drug Delivery System Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Ophthalmic Drug Delivery System Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Ophthalmic Drug Delivery System Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Ophthalmic Drug Delivery System Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Aero Pump GmbH
  2. 6.1.1 Aero Pump GmbH Company Information
  3. 6.1.2 Aero Pump GmbH Business Overview
  4. 6.1.3 Aero Pump GmbH Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Aero Pump GmbH Ophthalmic Drug Delivery System Product Portfolio
  6. 6.1.5 Aero Pump GmbH Recent Developments
  7. 6.2 AptarGroup
  8. 6.2.1 AptarGroup Company Information
  9. 6.2.2 AptarGroup Business Overview
  10. 6.2.3 AptarGroup Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 AptarGroup Ophthalmic Drug Delivery System Product Portfolio
  12. 6.2.5 AptarGroup Recent Developments
  13. 6.3 Bausch Health
  14. 6.3.1 Bausch Health Company Information
  15. 6.3.2 Bausch Health Business Overview
  16. 6.3.3 Bausch Health Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Bausch Health Ophthalmic Drug Delivery System Product Portfolio
  18. 6.3.5 Bausch Health Recent Developments
  19. 6.4 Becton Dickinson & Company
  20. 6.4.1 Becton Dickinson & Company Company Information
  21. 6.4.2 Becton Dickinson & Company Business Overview
  22. 6.4.3 Becton Dickinson & Company Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Becton Dickinson & Company Ophthalmic Drug Delivery System Product Portfolio
  24. 6.4.5 Becton Dickinson & Company Recent Developments
  25. 6.5 Biocorp Production
  26. 6.5.1 Biocorp Production Company Information
  27. 6.5.2 Biocorp Production Business Overview
  28. 6.5.3 Biocorp Production Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Biocorp Production Ophthalmic Drug Delivery System Product Portfolio
  30. 6.5.5 Biocorp Production Recent Developments
  31. 6.6 Clearside Biomedical
  32. 6.6.1 Clearside Biomedical Company Information
  33. 6.6.2 Clearside Biomedical Business Overview
  34. 6.6.3 Clearside Biomedical Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Clearside Biomedical Ophthalmic Drug Delivery System Product Portfolio
  36. 6.6.5 Clearside Biomedical Recent Developments
  37. 6.7 Envisia Therapeutics
  38. 6.7.1 Envisia Therapeutics Company Information
  39. 6.7.2 Envisia Therapeutics Business Overview
  40. 6.7.3 Envisia Therapeutics Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Envisia Therapeutics Ophthalmic Drug Delivery System Product Portfolio
  42. 6.7.5 Envisia Therapeutics Recent Developments
  43. 6.8 EyePoint Pharmaceuticals, Inc.
  44. 6.8.1 EyePoint Pharmaceuticals, Inc. Company Information
  45. 6.8.2 EyePoint Pharmaceuticals, Inc. Business Overview
  46. 6.8.3 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Product Portfolio
  48. 6.8.5 EyePoint Pharmaceuticals, Inc. Recent Developments
  49. 6.9 Gaplast GmbH
  50. 6.9.1 Gaplast GmbH Company Information
  51. 6.9.2 Gaplast GmbH Business Overview
  52. 6.9.3 Gaplast GmbH Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Gaplast GmbH Ophthalmic Drug Delivery System Product Portfolio
  54. 6.9.5 Gaplast GmbH Recent Developments
  55. 6.10 Gerresheimer
  56. 6.10.1 Gerresheimer Company Information
  57. 6.10.2 Gerresheimer Business Overview
  58. 6.10.3 Gerresheimer Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Gerresheimer Ophthalmic Drug Delivery System Product Portfolio
  60. 6.10.5 Gerresheimer Recent Developments
  61. 6.11 Graybug Vision
  62. 6.11.1 Graybug Vision Company Information
  63. 6.11.2 Graybug Vision Business Overview
  64. 6.11.3 Graybug Vision Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Graybug Vision Ophthalmic Drug Delivery System Product Portfolio
  66. 6.11.5 Graybug Vision Recent Developments
  67. 6.12 Kedalion Therapeutics
  68. 6.12.1 Kedalion Therapeutics Company Information
  69. 6.12.2 Kedalion Therapeutics Business Overview
  70. 6.12.3 Kedalion Therapeutics Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Kedalion Therapeutics Ophthalmic Drug Delivery System Product Portfolio
  72. 6.12.5 Kedalion Therapeutics Recent Developments
  73. 6.13 Mati Therapeutics, Inc.,
  74. 6.13.1 Mati Therapeutics, Inc., Company Information
  75. 6.13.2 Mati Therapeutics, Inc., Business Overview
  76. 6.13.3 Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Product Portfolio
  78. 6.13.5 Mati Therapeutics, Inc., Recent Developments
  79. 6.14 Nemera
  80. 6.14.1 Nemera Company Information
  81. 6.14.2 Nemera Business Overview
  82. 6.14.3 Nemera Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Nemera Ophthalmic Drug Delivery System Product Portfolio
  84. 6.14.5 Nemera Recent Developments
  85. 6.15 Nipro Corporation
  86. 6.15.1 Nipro Corporation Company Information
  87. 6.15.2 Nipro Corporation Business Overview
  88. 6.15.3 Nipro Corporation Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Nipro Corporation Ophthalmic Drug Delivery System Product Portfolio
  90. 6.15.5 Nipro Corporation Recent Developments
  91. 6.16 Ocular Therapeutix
  92. 6.16.1 Ocular Therapeutix Company Information
  93. 6.16.2 Ocular Therapeutix Business Overview
  94. 6.16.3 Ocular Therapeutix Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Ocular Therapeutix Ophthalmic Drug Delivery System Product Portfolio
  96. 6.16.5 Ocular Therapeutix Recent Developments
  97. 6.17 Ocumedic, Inc.
  98. 6.17.1 Ocumedic, Inc. Company Information
  99. 6.17.2 Ocumedic, Inc. Business Overview
  100. 6.17.3 Ocumedic, Inc. Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Ocumedic, Inc. Ophthalmic Drug Delivery System Product Portfolio
  102. 6.17.5 Ocumedic, Inc. Recent Developments
  103. 6.18 Owen Mumford
  104. 6.18.1 Owen Mumford Company Information
  105. 6.18.2 Owen Mumford Business Overview
  106. 6.18.3 Owen Mumford Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Owen Mumford Ophthalmic Drug Delivery System Product Portfolio
  108. 6.18.5 Owen Mumford Recent Developments
  109. 6.19 Re-Vana Therapeutics
  110. 6.19.1 Re-Vana Therapeutics Company Information
  111. 6.19.2 Re-Vana Therapeutics Business Overview
  112. 6.19.3 Re-Vana Therapeutics Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Re-Vana Therapeutics Ophthalmic Drug Delivery System Product Portfolio
  114. 6.19.5 Re-Vana Therapeutics Recent Developments
  115. 6.20 Santen Pharmaceutical
  116. 6.20.1 Santen Pharmaceutical Company Information
  117. 6.20.2 Santen Pharmaceutical Business Overview
  118. 6.20.3 Santen Pharmaceutical Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Santen Pharmaceutical Ophthalmic Drug Delivery System Product Portfolio
  120. 6.20.5 Santen Pharmaceutical Recent Developments
  121. 6.21 Silgan Holdings Inc.
  122. 6.21.1 Silgan Holdings Inc. Company Information
  123. 6.21.2 Silgan Holdings Inc. Business Overview
  124. 6.21.3 Silgan Holdings Inc. Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Silgan Holdings Inc. Ophthalmic Drug Delivery System Product Portfolio
  126. 6.21.5 Silgan Holdings Inc. Recent Developments
  127. 6.22 Taiwan Liposome
  128. 6.22.1 Taiwan Liposome Company Information
  129. 6.22.2 Taiwan Liposome Business Overview
  130. 6.22.3 Taiwan Liposome Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Taiwan Liposome Ophthalmic Drug Delivery System Product Portfolio
  132. 6.22.5 Taiwan Liposome Recent Developments
  133. 6.23 Terumo Corporation
  134. 6.23.1 Terumo Corporation Company Information
  135. 6.23.2 Terumo Corporation Business Overview
  136. 6.23.3 Terumo Corporation Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Terumo Corporation Ophthalmic Drug Delivery System Product Portfolio
  138. 6.23.5 Terumo Corporation Recent Developments
  139. 6.24 West Pharmaceutical Services, Inc.
  140. 6.24.1 West Pharmaceutical Services, Inc. Company Information
  141. 6.24.2 West Pharmaceutical Services, Inc. Business Overview
  142. 6.24.3 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Product Portfolio
  144. 6.24.5 West Pharmaceutical Services, Inc. Recent Developments
7 North America by Country
  1. 7.1 North America Ophthalmic Drug Delivery System Sales by Country
  2. 7.1.1 North America Ophthalmic Drug Delivery System Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Ophthalmic Drug Delivery System Sales by Country (2021-2026)
  4. 7.1.3 North America Ophthalmic Drug Delivery System Sales Forecast by Country (2027-2032)
  5. 7.2 North America Ophthalmic Drug Delivery System Market Size by Country
  6. 7.2.1 North America Ophthalmic Drug Delivery System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Ophthalmic Drug Delivery System Market Size by Country (2021-2026)
  8. 7.2.3 North America Ophthalmic Drug Delivery System Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Ophthalmic Drug Delivery System Sales by Country
  2. 8.1.1 Europe Ophthalmic Drug Delivery System Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Ophthalmic Drug Delivery System Sales by Country (2021-2026)
  4. 8.1.3 Europe Ophthalmic Drug Delivery System Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Ophthalmic Drug Delivery System Market Size by Country
  6. 8.2.1 Europe Ophthalmic Drug Delivery System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Ophthalmic Drug Delivery System Market Size by Country (2021-2026)
  8. 8.2.3 Europe Ophthalmic Drug Delivery System Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Ophthalmic Drug Delivery System Sales by Country
  2. 9.1.1 Asia-Pacific Ophthalmic Drug Delivery System Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Ophthalmic Drug Delivery System Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Ophthalmic Drug Delivery System Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Ophthalmic Drug Delivery System Market Size by Country
  6. 9.2.1 Asia-Pacific Ophthalmic Drug Delivery System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Ophthalmic Drug Delivery System Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Ophthalmic Drug Delivery System Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Ophthalmic Drug Delivery System Sales by Country
  2. 10.1.1 South America Ophthalmic Drug Delivery System Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Ophthalmic Drug Delivery System Sales by Country (2021-2026)
  4. 10.1.3 South America Ophthalmic Drug Delivery System Sales Forecast by Country (2027-2032)
  5. 10.2 South America Ophthalmic Drug Delivery System Market Size by Country
  6. 10.2.1 South America Ophthalmic Drug Delivery System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Ophthalmic Drug Delivery System Market Size by Country (2021-2026)
  8. 10.2.3 South America Ophthalmic Drug Delivery System Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Ophthalmic Drug Delivery System Sales by Country
  2. 11.1.1 Middle East and Africa Ophthalmic Drug Delivery System Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Ophthalmic Drug Delivery System Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Ophthalmic Drug Delivery System Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Ophthalmic Drug Delivery System Market Size by Country
  6. 11.2.1 Middle East and Africa Ophthalmic Drug Delivery System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Ophthalmic Drug Delivery System Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Ophthalmic Drug Delivery System Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Ophthalmic Drug Delivery System Value Chain Analysis
  2. 12.1.1 Ophthalmic Drug Delivery System Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Ophthalmic Drug Delivery System Production Mode & Process
  7. 12.2 Ophthalmic Drug Delivery System Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Ophthalmic Drug Delivery System Distributors
  10. 12.2.3 Ophthalmic Drug Delivery System Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst